Development of erythrocytosis in the course of essential thrombocythemia

被引：27

作者：

Jantunen, R

Juvonen, E

Ikkala, E

Oksanen, K

Anttila, P

Ruutu, T

机构：

[1] Helsinki Univ Cent Hosp, Dept Med, FIN-00029 Helsinki, Finland

[2] Kante Hame Cent Hosp, FIN-13530 Hameenlinna, Finland

[3] Helsinki Municipal Hosp, FIN-00180 Helsinki, Finland

来源：

ANNALS OF HEMATOLOGY | 1999年 / 78卷 / 05期

关键词：

essential thrombocythemia; thrombocytosis; erythrocytosis; erythroid progenitor;

D O I：

10.1007/s002770050505

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Erythrocytosis is not a feature of essential thrombocythemia (ET); this is the most important difference between ET and polycythemia vera (PV). Transformation of ET to PV has only rarely been described. We have reviewed the blood cell counts of 170 ET patients with a median follow-up of 63 months (range 11-313). Eleven of 170 patients (6.5%) developed erythrocytosis at a median of 29 months (range 12-138) after the diagnosis of ET. According to the present results, the development of erythrocytosis in patients with ET is not a rare phenomenon.

引用

页码：219 / 222

页数：4

共 19 条

[1]

BELLUCCI S, 1986, CANCER, V58, P2440, DOI 10.1002/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO

[2]

2-Y

[3]

BERK PD, 1986, SEMIN HEMATOL, V23, P132

[4]

DOKAL I, 1989, EUR J HAEMATOL, V42, P96

[5]

FENAUX P, 1990, CANCER, V66, P549, DOI 10.1002/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO

[6]

2-6

[7]

GARDAIS J, 1992, HAEMATOLOGICA, V77, P433

[8]

HASSELBALCH H, 1983, SCAND J HAEMATOL, V30, P161

[9]

HEHLMANN R, 1988, CANCER, V61, P2487, DOI 10.1002/1097-0142(19880615)61:12<2487::AID-CNCR2820611217>3.0.CO

[10]

2-T

← 1 2 →